|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Simard EP, Dorell C, Noone AM,
Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, et
al: Annual report to the nation on the status of cancer, 1975–2009,
featuring the burden and trends in human papillomavirus
(HPV)-associated cancers and HPV vaccination coverage levels. J
Natl Cancer Inst. 105:175–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pedersen K, Burger EA, Nygård M,
Kristiansen IS and Kim JJ: Adapting cervical cancer screening for
women vaccinated against human papillomavirus infections: The value
of stratifying guidelines. Eur J Cancer. 91:68–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Philp L, Jembere N, Wang L, Gao J, Maguire
B and Kupets R: Pap tests in the diagnosis of cervical cancer: Help
or hinder? Gynecol Oncol. 150:61–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bogani G, Leone Roberti Maggiore U,
Signorelli M, Martinelli F, Ditto A, Sabatucci I, Mosca L, Lorusso
D and Raspagliesi F: The role of human papillomavirus vaccines in
cervical cancer: Prevention and treatment. Crit Rev Oncol Hematol.
122:92–97. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lytwyn A, Elit L and Sellors JW: Human
papillomavirus DNA versus papanicolaou screening tests for cervical
cancer. N Engl J Med. 358:6412008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yaşar P, Ayaz G, User SD, Güpür G and
Muyan M: Molecular mechanism of estrogen-estrogen receptor
signaling. Reprod Med Biol. 16:4–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bado I, Gugala Z, Fuqua SAW and Zhang XH:
Estrogen receptors in breast and bone: From virtue of remodeling to
vileness of metastasis. Oncogene. 36:4527–4537. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Robinson DR, Wu YM, Vats P, Su F, Lonigro
RJ, Cao X, Kalyana-Sundaram S, Wang R, Ning Y, Hodges L, et al:
Activating ESR1 mutations in hormone-resistant metastatic breast
cancer. Nat Genet. 45:1446–1451. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toy W, Shen Y, Won H, Green B, Sakr RA,
Will M, Li Z, Gala K, Fanning S, King TA, et al: ESR1
ligand-binding domain mutations in hormone-resistant breast cancer.
Nat Genet. 45:1439–1445. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartels S, Christgen M, Luft A, Persing S,
Jödecke K, Lehmann U and Kreipe H: Estrogen receptor (ESR1)
mutation in bone metastases from breast cancer. Mod Pathol.
31:56–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yanagawa T, Kagara N, Miyake T, Tanei T,
Naoi Y, Shimoda M, Shimazu K, Kim SJ and Noguchi S: Detection of
ESR1 mutations in plasma and tumors from metastatic breast cancer
patients using next-generation sequencing. Breast Cancer Res Treat.
163:231–240. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lefebvre C, Bachelot T, Filleron T,
Pedrero M, Campone M, Soria JC, Massard C, Lévy C, Arnedos M,
Lacroix-Triki M, et al: Mutational profile of metastatic breast
cancers: A retrospective analysis. PLoS Med. 13:e10022012016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clarke R, Tyson JJ and Dixon JM: Endocrine
resistance in breast cancer-An overview and update. Mol Cell
Endocrinol. 418:220–234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Backes FJ, Walker CJ, Goodfellow PJ, Hade
EM, Agarwal G, Mutch D, Cohn DE and Suarez AA: Estrogen
receptor-alpha as a predictive biomarker in endometrioid
endometrial cancer. Gynecol Oncol. 141:312–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cancer Genome Atlas Network, ; Muzny DM,
Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, Kovar CL,
Lewis LR, Morgan MB, et al: Comprehensive molecular
characterization of human colon and rectal cancer. Nature.
487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ojesina AI, Lichtenstein L, Freeman SS,
Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio
L, Cibulskis K, Bertelsen B, et al: Landscape of genomic
alterations in cervical carcinomas. Nature. 506:371–375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muller E, Brault B, Holmes A, Legros A,
Jeannot E, Campitelli M, Rousselin A, Goardon N, Frébourg T,
Krieger S, et al: Genetic profiles of cervical tumors by
high-throughput sequencing for personalized medical care. Cancer
Med. 4:1484–1493. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sjöblom T, Jones S, Wood LD, Parsons DW,
Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al:
The consensus coding sequences of human breast and colorectal
cancers. Science. 314:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Banerji S, Cibulskis K, Rangel-Escareno C,
Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY,
Sougnez C, Zou L, et al: Sequence analysis of mutations and
translocations across breast cancer subtypes. Nature. 486:405–409.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cancer Genome Atlas Research Network;
Albert Einstein College of Medicine; Analytical Biological
Services; Barretos Cancer Hospital; Baylor College of Medicine;
Beckman Research Institute of City of Hope; Buck Institute for
Research on Aging; Canada's Michael Smith Genome Sciences Centre;
Harvard Medical School; Helen F. Graham Cancer Center &
Research Institute at Christiana Care Health Services, ; et al
Integrated genomic and molecular characterization of cervical
cancer. Nature. 543:378–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
den Boon JA, Pyeon D, Wang SS, Horswill M,
Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et
al: Molecular transitions from papillomavirus infection to cervical
precancer and cancer: Role of stromal estrogen receptor signaling.
Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bronowicka-Kłys DE, Lianeri M and
Jagodziński PP: The role and impact of estrogens and xenoestrogen
on the development of cervical cancer. Biomed Pharmacother.
84:1945–1953. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leung YK, Lee MT, Lam HM, Tarapore P and
Ho SM: Estrogen receptor-beta and breast cancer: Translating
biology into clinical practice. Steroids. 77:727–737. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vazquez Rodriguez G, Abrahamsson A, Jensen
LD and Dabrosin C: Estradiol promotes breast cancer cell migration
via recruitment and activation of neutrophils. Cancer Immunol Res.
5:234–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zou Y, Liu FY, Wu J, Wan L, Fang SF, Zhang
ZY, Luo Y, Chen MH, Huang MZ, He M and Huang OP: Mutational
analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 Han
Chinese patients with cervical carcinoma. Oncol Lett. 14:2427–2431.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schwarz JM, Cooper DN, Schuelke M and
Seelow D: MutationTaster2: Mutation prediction for the
deep-sequencing age. Nat Methods. 11:361–362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tamura K, Dudley J, Nei M and Kumar S:
MEGA4: Molecular evolutionary genetics analysis (MEGA) software
version 4.0. Mol Biol Evol. 24:1596–1599. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johansson MU, Zoete V, Michielin O and
Guex N: Defining and searching for structural motifs using
DeepView/Swiss-PdbViewer. BMC Bioinformatics. 13:1732012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koide A, Abbatiello S, Rothgery L and
Koide S: Probing protein conformational changes in living cells by
using designer binding proteins: Application to the estrogen
receptor. Proc Natl Acad Sci USA. 99:1253–1258. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
1000 Genomes Project Consortium, ;
Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker
RE, Kang HM, Marth GT and McVean GA: An integrated map of genetic
variation from 1,092 human genomes. Nature. 491:56–65. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lek M, Karczewski KJ, Minikel EV, Samocha
KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ,
Cummings BB, et al: Analysis of protein-coding genetic variation in
60,706 humans. Nature. 536:285–291. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fuqua SA, Wiltschke C, Zhang QX, Borg A,
Castles CG, Friedrichs WE, Hopp T, Hilsenbeck S, Mohsin S,
O'Connell P and Allred DC: A hypersensitive estrogen receptor-alpha
mutation in premalignant breast lesions. Cancer Res. 60:4026–4029.
2000.PubMed/NCBI
|
|
35
|
Conway K, Parrish E, Edmiston SN, Tolbert
D, Tse CK, Geradts J, Livasy CA, Singh H, Newman B and Millikan RC:
The estrogen receptor-alpha A908G (K303R) mutation occurs at a low
frequency in invasive breast tumors: Results from a
population-based study. Breast Cancer Res. 7:R871–R880. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Herynk MH, Parra I, Cui Y, Beyer A, Wu MF,
Hilsenbeck SG and Fuqua SA: Association between the estrogen
receptor alpha A908G mutation and outcomes in invasive breast
cancer. Clin Cancer Res. 13:3235–3243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Abbasi S, Rasouli M, Nouri M and Kalbasi
S: Association of estrogen receptor-α A908G (K303R) mutation with
breast cancer risk. Int J Clin Exp Med. 6:39–49. 2013.PubMed/NCBI
|
|
38
|
Lim B, Mun J, Kim JH, Kim CW, Roh SA, Cho
DH, Kim YS, Kim SY and Kim JC: Genome-wide mutation profiles of
colorectal tumors and associated liver metastases at the exome and
transcriptome levels. Oncotarget. 6:22179–22190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang P, Bahreini A, Gyanchandani R, Lucas
PC, Hartmaier RJ, Watters RJ, Jonnalagadda AR, Trejo Bittar HE,
Berg A, Hamilton RL, et al: Sensitive detection of mono- and
polyclonal ESR1 mutations in primary tumors, metastatic lesions,
and cell-free DNA of breast cancer patients. Clin Cancer Res.
22:1130–1137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Niu J, Andres G, Kramer K, Kundranda MN,
Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED and Markman M:
Incidence and clinical significance of ESR1 mutations in heavily
pretreated metastatic breast cancer patients. Onco Targets Ther.
8:3323–3328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Takeshita T, Yamamoto Y, Yamamoto-Ibusuki
M, Inao T, Sueta A, Fujiwara S, Omoto Y and Iwase H: Droplet
digital polymerase chain reaction assay for screening of ESR1
mutations in 325 breast cancer specimens. Transl Res.
166:540–553.e2. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cui Y, Zhang M, Pestell R, Curran EM,
Welshons WV and Fuqua SA: Phosphorylation of estrogen receptor
alpha blocks its acetylation and regulates estrogen sensitivity.
Cancer Res. 64:9199–9208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Toy W, Weir H, Razavi P, Lawson M,
Goeppert AU, Mazzola AM, Smith A, Wilson J, Morrow C, Wong WL, et
al: Activating ESR1 mutations differentially affect the efficacy of
ER antagonists. Cancer Discov. 7:277–287. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Segovia-Mendoza M, Jurado R, Mir R, Medina
LA, Prado-Garcia H and Garcia-Lopez P: Antihormonal agents as a
strategy to improve the effect of chemo-radiation in cervical
cancer: In vitro and in vivo study. BMC Cancer. 15:212015.
View Article : Google Scholar : PubMed/NCBI
|
